Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Pharmaceutical Group Co.,Ltd. was founded in 2003 and is based in Shannan, China.
Research context
Lionco Pharmaceutical Group Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Lionco Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 29.2% below its 200 day moving average.
From a valuation standpoint, the stock is 46.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
Lionco Pharmaceutical Group Co., Ltd's total revenue sank by 20.9% to $296M since the same quarter in the previous year.
Its net income has increased by 84.6% to $76M since the same quarter in the previous year.
Finally, its free cash flow fell by 48.0% to $23M since the same quarter in the previous year.
Based on the above factors, Lionco Pharmaceutical Group Co., Ltd gets an overall score of 2/5.